Search results for " growth"
Article
Global Expansion Shapes Drug Oversight
DIA’s chief executive, Barbara Lopez Kunz, came from Battelle with strong international management experience to oversee DIA’s worldwide growth, which will be highlighted at its 50th annual meeting th…
Article
Biopharma Takes a Nervous Glance Over Its Shoulder
Biopharmaceutical Industry: Perspectives on Future Growth and The Factors That Will Drive It, published by Battelle and the Pharmaceutical Research and Manufacturers Association or PhRMA. The conclusi…
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Comparable rates of growth are also seen with outsourcing of design of experiments (from 21.4% to 43.2%) and quality-by-design (QbD) services (from 19.3% to 42%). These activities are still at the bot…
Article
The Affordable Care Act's Impact on Innovation in Biopharma
According to a Rand study, increased family contributions to healthcare absorbed almost half of the growth in US before-tax income from 1999 to 2009 (3). Howard Shultz, Starbucks CEO, has been quoted …
Article
Comparing Protein A Resins for Monoclonal Antibody Purification
Today, mAbs constitute the single largest class of biological drugs and accounts for about 36% of the total biologics market with an annual sales growth rate of approximately 10% (4).
Com…
Article
State of Quality and Compliance in the Biopharmaceutical Industry
…reased company profitability, and lowered employee morale—each a major challenge to innovation and growth. Situations like this have led to a slew of industry mergers and acquisitions designed to fos…
Article
Report from India
…available to those who need them most by managing prices in the retail market and balancing industry growth on a longer-term perspective."
Impact on consumers
While consumers could…
Article
QbD and PAT in Upstream and Downstream Processing
Initial seed density can impact the overall growth profile and viability. Temperature is critical in maintaining viability and may impact the quality of product being produced by the cells. Process du…
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
The cell growth rate was shown to be similar in both the 10 L and 50 L cultures in three consecutive batches (Fig 3).
In the 50 L cultures, cells were grown to a cell density of approximately 2 × …
Article
Milestones and Moderate Progress in 2012 Drug Approvals
The final product listed in Table I is Zaltrap, a recombinant fusion protein consisting of vascular endothelial growth factor (VEGF)-binding portions derived from VEGF receptors 1 and 2, fused to the …